RNAi Therapeutics

Silence Therapeutics has created two powerful platforms and a strong pipeline to exploit the Company's impressive technological know-how and IP.

RNAi Platform

Delivery Platform

Products Pipeline

Combined, the RNAi and delivery platforms enable the development of multiple products to multiple drug targets allowing the development of novel therapeutics to diseases with high unmet medical need.

Silence Therapeutics wants to capitalise on these, its core competencies, to bring to market the next generation of therapeutic agents (RNAi therapeutics) alongside current small molecule and biological therapies.